News

AddToAny

Google+ Facebook Twitter Twitter

AI for blood vessel anomalies and eye disease

An international team of scientists has developed an artificial intelligence (AI) platform that could one day be used in a system to assess vascular diseases that are characterised by the abnormal condition of blood vessels.

The AI-powered platform combines machine learning and a specially designed microfluidic chip with analysis of 2D video images of blood flow and the application of physical laws, to infer how blood flows in 3D.

In tests it accurately predicted blood flow characteristics, such as speed, pressure, and shear stress, which is the stress exerted by the blood flow on the vessel wall.

The ability to determine these characteristics accurately could be a critical support for clinicians in detecting and tracking the progression of vascular diseases since the abnormalities that the platform could spot may indicate the presence or progression of a vascular disease.

The scientists tested it on simulated microaneurysms of the eye, using a microfluidic chip that is smaller than a thumbnail.

When the platform was given images of blood flow in a device that simulates microaneurysms, it successfully predicted the characteristics of blood circulation within it.

bit.ly/39yuCTU

Image credit | iStock

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top